<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04826380</url>
  </required_header>
  <id_info>
    <org_study_id>3163/2020</org_study_id>
    <nct_id>NCT04826380</nct_id>
  </id_info>
  <brief_title>Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Cinematics and Cost-utility</brief_title>
  <official_title>Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Kinematics and Cost-utility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Töölö Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Töölö Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A project aiming to promote evidence based practice when treating thumb basal joint (CMC I)&#xD;
      arthritis. We will aim to: 1) provide the minimal clinical difference of two general outcome&#xD;
      instruments, 2) evaluate the association between pre-operative anxiety and/or depression and&#xD;
      outcomes following trapeziectomy, 3) evaluate the effect of trapziectomy on carpal&#xD;
      cinematics, 4) determine the cost-utility-ratio of trapeziectomy&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-Rated Wrist Evaluation</measure>
    <time_frame>12 months</time_frame>
    <description>The PRWE comprises 15 questions to measure wrist pain and disability in daily activities. In PRWE patients rate wrist pain and disability from 0 to 10 and it consists two subscales: Pain and Function (0=best possible outcome, 10=worst possible outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Michigan Hand Outcome Questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>A hand-specific outcomes instrument that contains six distinct scales: (1) overall hand function, (2) activities of daily living, (3) pain, (4) work performance, (5) aesthetics, and (6) patient satisfaction with hand function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing Scale</measure>
    <time_frame>12 months</time_frame>
    <description>A pain catastrophizing scale comprising of three subscales: (1) Helplessness, (2) Rumination, and (3) Magnification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain (Visual Analogue Scale)</measure>
    <time_frame>12 months</time_frame>
    <description>The VAS is derived by health care professional question of pain in scale 0 to 10 (0=no pain, 10=worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global improvemen</measure>
    <time_frame>12 months</time_frame>
    <description>Global rating to treatment effect will be evaluated by question: &quot;How would you rate the function of your hand compared to the situation before the treatment?&quot;. The options are in 5-step Likert scale from (-2) Much worse to (+2) Much better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>12 months</time_frame>
    <description>Grip strength is measured with a dynamometer in kg as the mean of three measurements. It will be numbered in kg and percentage of the unaffected side</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wrist and hand (thumb) range of motion (ROM)</measure>
    <time_frame>12 months</time_frame>
    <description>ROM is measured on both hands with a handheld goniometer in degrees.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-utility</measure>
    <time_frame>12 months</time_frame>
    <description>Quality-adjusted life years/months measured as a change in EQ-5D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carpal Kinematics</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluated from preoperative and compared to 1-year postoperative 4-dimension cone-beam tomography - the wrists are imaged in 7 different postures to reproduce carpal movement, the pre and postoperative scans will be compared to evalueate the effect of trapeziectomy on carpal kinematics (e.g. scapholunate angle, lunotriquetral angle, metacarpal subsidence)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory</measure>
    <time_frame>12 months</time_frame>
    <description>21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Arthritis</condition>
  <condition>Thumb Osteoarthritis</condition>
  <condition>Arthropathy</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Trapeziectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Simple trapeziectomy for treating CMC I arthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conservative measures (e.g. splint, NSAID, activation modification) for treating CMC I arthritis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trapeziectomy</intervention_name>
    <description>Simple trapeziectomy (without LRTI)</description>
    <arm_group_label>Trapeziectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eaton-Glickel &gt;2 arhritis&#xD;
&#xD;
          -  Symptom duration &gt;3 months&#xD;
&#xD;
          -  Pain VAS &gt;30mm&#xD;
&#xD;
          -  No significant comorbidities, ASA I-II&#xD;
&#xD;
          -  Fluent in Finnish language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Eaton-Glickel &lt;2&#xD;
&#xD;
          -  Duration of symptoms &lt;3 months&#xD;
&#xD;
          -  VAS &lt;30mm&#xD;
&#xD;
          -  ASA &gt;II&#xD;
&#xD;
          -  Inflammatory joint disease&#xD;
&#xD;
          -  Systemic corticosteroid or immunomodulatory medication&#xD;
&#xD;
          -  Upper limb symptoms not explained with CMC I artritis&#xD;
&#xD;
          -  Heavy smoking (&gt; 20 cigarettes per day)&#xD;
&#xD;
          -  Alcohol or drug abuse&#xD;
&#xD;
          -  Neurological condition affecting upper limb function&#xD;
&#xD;
          -  Other ipsilateral upper limb condition requiring surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samuli Aspinen, M.D., Ph.D.</last_name>
    <phone>+358406360546</phone>
    <email>samuli.aspinen@hus.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Töölö Hospital (Helsinki University Hospital)</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuli Aspinen, M.D., Ph.D.</last_name>
      <phone>+358406360546</phone>
      <email>samuli.aspinen@hus.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Töölö Hospital</investigator_affiliation>
    <investigator_full_name>Samuli Aspinen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The datasets generated and analyzed during this trial will be available from the PI on reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

